Cargando…

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma

Mesothelioma (MESO) is an infrequent tumor derived from mesothelial cells of pleura, peritoneum, pericardium, and tunica vaginalis testis. Despite advancement in technologies and better understanding of tumor progression mechanism, the prognosis of MESO remains poor. The role of alternative splicing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Runzhi, Zheng, Zixuan, Liu, Sijia, Yan, Penghui, Song, Dianwen, Yin, Huabin, Hu, Peng, Zhu, Xiaolong, Chang, Zhengyan, Liu, Yihan, Zhuang, Juanwei, Meng, Tong, Huang, Zongqiang, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267146/ https://www.ncbi.nlm.nih.gov/pubmed/34041868 http://dx.doi.org/10.1002/cam4.3977

Ejemplares similares

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis
por: Huang, Runzhi, et al.
Publicado: (2019)

The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma
por: Huang, Runzhi, et al.
Publicado: (2022)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Prostate Cancer
por: Zhuang, Juanwei, et al.
Publicado: (2022)

The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma
por: Huang, Runzhi, et al.
Publicado: (2019)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Collagen Type III Alpha 1 chain regulated by GATA‐Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma
por: Huang, Runzhi, et al.
Publicado: (2020)

The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma
por: Huang, Runzhi, et al.
Publicado: (2019)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

Construction and validation of nomograms for non-metastatic Ewing sarcoma: A prognostic factor analysis based on the SEER database
por: Huang, Runzhi, et al.
Publicado: (2021)

Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma
por: Hao, Zhiquan, et al.
Publicado: (2022)

Prognostic Factors for Survival in Patients with Malignant Giant Cell Tumor of Bone: A Risk Nomogram Analysis Based on the Population
por: Zhu, Xiaolong, et al.
Publicado: (2021)

Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme
por: Huang, Runzhi, et al.
Publicado: (2020)

An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors
por: Wang, Yidi, et al.
Publicado: (2020)

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis
por: Chang, Zhengyan, et al.
Publicado: (2020)

The Integrated Transcriptome Bioinformatics Analysis Identifies Key Genes and Cellular Components for Spinal Cord Injury-Related Neuropathic Pain
por: Huang, Runzhi, et al.
Publicado: (2020)

Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study
por: Huang, Runzhi, et al.
Publicado: (2019)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing
por: Mao, Shuangshuang, et al.
Publicado: (2019)

Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma
por: Huang, Runzhi, et al.
Publicado: (2021)

The Roles of Magnetic Resonance-Guided Focused Ultrasound in Pain Relief in Patients With Bone Metastases: A Systemic Review and Meta-Analysis
por: Han, Xiaying, et al.
Publicado: (2021)

Research hotspots and trends of chordoma: A bibliometric analysis
por: Gao, Jianxuan, et al.
Publicado: (2022)

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes
por: Zhuang, Aojia, et al.
Publicado: (2023)

The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma
por: Jiang, Yue, et al.
Publicado: (2022)

An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
por: Li, Ji, et al.
Publicado: (2018)

Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer
por: Xu, Tong, et al.
Publicado: (2022)

Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018)

Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma
por: Lai, Jinzhi, et al.
Publicado: (2021)

Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review
por: Meng, Tong, et al.
Publicado: (2019)

A four‐gene signature associated with clinical features can better predict prognosis in prostate cancer
por: Yuan, Penghui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sgue330co1nnpma5ijupi3ii1t